442 related articles for article (PubMed ID: 31341410)
1. Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights.
Faverio P; De Giacomi F; Bonaiti G; Stainer A; Sardella L; Pellegrino G; Sferrazza Papa GF; Bini F; Bodini BD; Carone M; Annoni S; Messinesi G; Pesci A
Int J Med Sci; 2019; 16(7):967-980. PubMed ID: 31341410
[TBL] [Abstract][Full Text] [Related]
2. Management of acute respiratory failure in interstitial lung diseases: overview and clinical insights.
Faverio P; De Giacomi F; Sardella L; Fiorentino G; Carone M; Salerno F; Ora J; Rogliani P; Pellegrino G; Sferrazza Papa GF; Bini F; Bodini BD; Messinesi G; Pesci A; Esquinas A
BMC Pulm Med; 2018 May; 18(1):70. PubMed ID: 29764401
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Tolerability of High-Flow Nasal Cannula Oxygen Therapy for Hypoxemic Respiratory Failure in Patients with Interstitial Lung Disease with Do-Not-Intubate Orders: A Retrospective Single-Center Study.
Koyauchi T; Hasegawa H; Kanata K; Kakutani T; Amano Y; Ozawa Y; Matsui T; Yokomura K; Suda T
Respiration; 2018; 96(4):323-329. PubMed ID: 29954000
[TBL] [Abstract][Full Text] [Related]
4. Supplemental Oxygen in Interstitial Lung Disease: An Art in Need of Science.
Johannson KA; Pendharkar SR; Mathison K; Fell CD; Guenette JA; Kalluri M; Kolb M; Ryerson CJ
Ann Am Thorac Soc; 2017 Sep; 14(9):1373-1377. PubMed ID: 28644693
[TBL] [Abstract][Full Text] [Related]
5. Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: a post-hoc analysis of a randomised trial.
Frat JP; Ragot S; Girault C; Perbet S; Prat G; Boulain T; Demoule A; Ricard JD; Coudroy R; Robert R; Mercat A; Brochard L; Thille AW;
Lancet Respir Med; 2016 Aug; 4(8):646-652. PubMed ID: 27245914
[TBL] [Abstract][Full Text] [Related]
6. Incidence and Prognostic Significance of Hypoxemia in Fibrotic Interstitial Lung Disease: An International Cohort Study.
Khor YH; Gutman L; Abu Hussein N; Johannson KA; Glaspole IN; Guler SA; Funke-Chambour M; Geiser T; Goh NSL; Ryerson CJ
Chest; 2021 Sep; 160(3):994-1005. PubMed ID: 33905679
[TBL] [Abstract][Full Text] [Related]
7. Treatment of acute exacerbations of interstitial lung disease.
Azadeh N; Moua T; Baqir M; Ryu JH
Expert Rev Respir Med; 2018 Apr; 12(4):309-313. PubMed ID: 29486130
[TBL] [Abstract][Full Text] [Related]
8. Interstitial lung disease and pulmonary rehabilitation.
Garvey C
J Cardiopulm Rehabil Prev; 2010; 30(3):141-6. PubMed ID: 20040881
[TBL] [Abstract][Full Text] [Related]
9. The effect of domiciliary high flow nasal cannula treatment on dyspnea and walking distance in patients with interstitial lung disease - A pilot study.
Weinreich UM; Burchardt C; Huremovic J
Chron Respir Dis; 2022; 19():14799731221137085. PubMed ID: 36366859
[TBL] [Abstract][Full Text] [Related]
10. Oxygen for interstitial lung diseases.
Khor YH; Smith DJF; Johannson KA; Renzoni E
Curr Opin Pulm Med; 2020 Sep; 26(5):464-469. PubMed ID: 32657832
[TBL] [Abstract][Full Text] [Related]
11. Predicting New-onset Exertional and Resting Hypoxemia in Fibrotic Interstitial Lung Disease.
Saleem F; Ryerson CJ; Sarma N; Johannson K; Marcoux V; Fisher J; Assayag D; Manganas H; Khalil N; Morisset J; Glaspole IN; Goh N; Oldham JM; Cox G; Fell C; Gershon AS; Halayko A; Hambly N; Lok SD; Shapera S; To T; Wilcox PG; Wong AW; Kolb M; Khor YH
Ann Am Thorac Soc; 2023 Dec; 20(12):1726-1734. PubMed ID: 37676933
[No Abstract] [Full Text] [Related]
12. Exertional hypoxemia is more severe in fibrotic interstitial lung disease than in COPD.
Du Plessis JP; Fernandes S; Jamal R; Camp P; Johannson K; Schaeffer M; Wilcox PG; Guenette JA; Ryerson CJ
Respirology; 2018 Apr; 23(4):392-398. PubMed ID: 29193512
[TBL] [Abstract][Full Text] [Related]
13. Respiratory failure in interstitial lung disease.
Bag R; Suleman N; Guntupalli KK
Curr Opin Pulm Med; 2004 Sep; 10(5):412-8. PubMed ID: 15316441
[TBL] [Abstract][Full Text] [Related]
14. Improving home oxygen therapy in patients with interstitial lung diseases: application of a noninvasive ventilation device.
Cuerpo S; Palomo M; Hernández-González F; Francesqui J; Albacar N; Hernández C; Blanco I; Embid C; Sellares J
Ther Adv Respir Dis; 2020; 14():1753466620963027. PubMed ID: 33086990
[TBL] [Abstract][Full Text] [Related]
15. Supplemental oxygen for the management of dyspnea in interstitial lung disease.
Schaeffer MR; Molgat-Seon Y; Ryerson CJ; Guenette JA
Curr Opin Support Palliat Care; 2019 Sep; 13(3):174-178. PubMed ID: 31145136
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive Respiratory Support at the End of Life.
Davies JD
Respir Care; 2019 Jun; 64(6):701-711. PubMed ID: 31110038
[TBL] [Abstract][Full Text] [Related]
17. Exertional Desaturation and Prescription of Ambulatory Oxygen Therapy in Interstitial Lung Disease.
Khor YH; Goh NS; Glaspole I; Holland AE; McDonald CF
Respir Care; 2019 Mar; 64(3):299-306. PubMed ID: 30377245
[TBL] [Abstract][Full Text] [Related]
18. Interstitial lung diseases in the hospitalized patient.
Disayabutr S; Calfee CS; Collard HR; Wolters PJ
BMC Med; 2015 Sep; 13():245. PubMed ID: 26407727
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Oxygen Therapy in COPD Patients Who Do Not Meet the Actual Recommendations.
Ergan B; Nava S
COPD; 2017 Jun; 14(3):351-366. PubMed ID: 28506089
[TBL] [Abstract][Full Text] [Related]
20. High-Flow Nasal Oxygen vs Noninvasive Positive Airway Pressure in Hypoxemic Patients After Cardiothoracic Surgery: A Randomized Clinical Trial.
Stéphan F; Barrucand B; Petit P; Rézaiguia-Delclaux S; Médard A; Delannoy B; Cosserant B; Flicoteaux G; Imbert A; Pilorge C; Bérard L;
JAMA; 2015 Jun; 313(23):2331-9. PubMed ID: 25980660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
